期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

早期乳腺癌术后芳香化酶抑制剂辅助治疗研究新进展

New progress in postoperative adjuvant chemotherapy of mammary carcinoma with aromatase inhibitors
下载PDF
导出
摘要 三苯氧胺(TAM)是激素依赖型乳腺癌患者术后辅助治疗的标准药物.
作者 王涛 江泽飞
机构地区 军事医学科学院附属医院
出处 《临床药物治疗杂志》 2005年第3期23-27,共5页 Clinical Medication Journal
关键词 芳香化酶抑制剂 研究新进展 乳腺癌术后 术后辅助治疗 乳腺癌患者 激素依赖型 早期 临床试验结果 LANCET 1998年 TAM治疗 “金标准” 部分激动剂 雌激素受体 三苯氧胺 荟萃分析 骨质丢失 死亡率 复发率
分类号 R737.9 [医药卫生—肿瘤] R87 [医药卫生—运动医学]
  • 相关文献

参考文献22

  • 1[1]Early Breast Cancer Trialists Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet, 1998,351:1451～1467
  • 2[2]Love RR, Barden HS, Mazess RB, et al. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years. Arch Inter Med, 1994,154:2585～2588
  • 3[3]Cuzick J, Powles T, Veronesi U, et al. Overview of the main outcomes in breast - cancer prevention trials. Lancet, 2003,361:296～300
  • 4[4]Osborne CK, Schiff R. Growth factor receptor cross - talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer. Breast, 2003,12: 362～367
  • 5[5]Fish B, Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen for lymph node - negative breast cancer:updated findings from the National Surgical Adjuvant Breast and Bowel Project B - 14 randomized trial. J Natl Cancer Inst,2001,93:684～690
  • 6[6]Brodie AM, Njar VC. Aromatase inhibitors and breast cancer. Semin Oncol, 1996,23:10～20
  • 7[7]Bonneterre J, Buzdar A, Nabholtz JM, et al. Anastrozole is superior to tamoxifen as first - line therapy in hormone receptor positive advanced breast carcinoma. Results of two randomized trials designed for combined analysis. Cancer, 2001,92: 2247～2258
  • 8[8]Mouridsen H, Gershanovich M, Sun Y, et al. Phase Ⅲ study of letrozole versus tamoxifen as first - line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol,2003,21:2101～2109
  • 9[9]Paridaeas R, Dirix L, Lohrisch C, et al. Mature results of a randomized phase Ⅱ multicenter study of exemestane versus tamoxifen as first - line hormone therapy for postmenopausal women with metastatic breast cancer. Ann Oncol, 2003, 14:1391～1398
  • 10[10]Buzdar AU, Jonat W, Howell A, et al. Anastrozole versus megestrol acetate in the treatment of postmenopaasal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature Phase Ⅲtrials. Arimidex Study Group, Cancer, 1998,83:1142～1152

二级参考文献8

  • 1Early Breast Cancer Trialists'Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials [J]. Lancet, 1998, 351:1451.
  • 2Coombes RC,Hall E,Gibson LJ,et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer [J]. N Engl J Med, 2004, 350(11):1081-1092.
  • 3Baum M, Buzdar AU, Cuzik J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer:first results of the ATAC randomised trial [J]. Lancet, 2002,359(9324) :2131-2139.
  • 4Goss PE, Ingle JN, Martino S, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer [J]. N Engl J Med, 2003,349(19): 1793-1802.
  • 5宋三泰,江泽飞.乳腺癌内分泌治疗的现状及应用策略[J].中华肿瘤杂志,1999,21(4):312-313. 被引量：20
  • 6江泽飞,宋三泰.乳腺癌辅助内分泌治疗若干问题的新认识[J].中华肿瘤杂志,2001,23(1):81-82. 被引量：28
  • 7江泽飞,宋三泰.乳腺癌术后辅助治疗最新指导原则[J].肿瘤研究与临床,2001,13(5):293-295. 被引量：38
  • 8江泽飞,宋三泰.乳腺癌内分泌治疗的新思路和新策略[J].中华肿瘤杂志,2003,25(4):410-411. 被引量：40

共引文献44

临床药物治疗杂志
2005年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部